Bleakley Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.65M | Sell |
13,925
-540
| -4% | -$219K | 0.14% | 135 |
|
|
2025
Q1 | $7.2M | Buy |
14,465
+2,597
| +22% | +$1.29M | 0.23% | 83 |
|
|
2024
Q4 | $6.17M | Buy |
11,868
+812
| +7% | +$422K | 0.19% | 92 |
|
|
2024
Q3 | $6.84M | Sell |
11,056
-13,617
| -55% | -$8.42M | 0.21% | 84 |
|
|
2024
Q2 | $13.6M | Sell |
24,673
-164
| -0.7% | -$90.7K | 0.39% | 44 |
|
|
2024
Q1 | $14.4M | Sell |
24,837
-5,880
| -19% | -$3.42M | 0.42% | 41 |
|
|
2023
Q4 | $16.3M | Sell |
30,717
-965
| -3% | -$512K | 0.52% | 36 |
|
|
2023
Q3 | $16M | Buy |
31,682
+3,713
| +13% | +$1.88M | 0.57% | 34 |
|
|
2023
Q2 | $14.6M | Sell |
27,969
-1,089
| -4% | -$568K | 0.46% | 41 |
|
|
2023
Q1 | $16.7M | Buy |
29,058
+718
| +3% | +$414K | 0.56% | 32 |
|
|
2022
Q4 | $15.6M | Buy |
+28,340
| New | +$15.6M | 0.56% | 34 |
|